CTI Biopharma Corp (NASDAQ:CTIC)

Delayed Data
As of Aug 12
 +0.07 / +1.23%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for CTI Biopharma Corp have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 7.90. The median estimate represents a +73.01% increase from the last price of 5.78.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in CTI Biopharma Corp. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 26.73%
Growthannually 25.34%


Growthquarterly 43.00%
Growthannually --
Key to the earnings and sales forecast charts.